Drug Delivery Devices Global Market Report 2022 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 200 | Published : March 2022 | SKU CODE : 7624 | Delivery Time: 2-3 business days | Format :


The drug delivery devices market consists of the sales of medical devices and equipment that are used for delivering specific drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases.

The main route of administration of drug delivery devices are oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery is a route of drug delivery in which a tablet or capsule is administered into the alimentary canal of a human being. The patient care setting is hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The various applications involved are cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and others.

The global drug delivery devices market size is expected to grow from $79.68 billion in 2021 to $84.1 billion in 2022 at a compound annual growth rate (CAGR) of 5.5%. The global drug delivery device market size is then expected to grow to $100.1 billion in 2026 at a CAGR of 4.5%.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. According to the World Health Organization (WHO), by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. There are various routes of drug administration for medical drugs. The selection of the route depends on three factors – the effect desired, the type of the disease and the type of the product. Currently, the development of new drug delivery systems plays a major role in pharmaceutical industries. Research and development (R&D) in drug delivery are increasing throughout the world due to increasing prevalence of these diseases. Most of the pharmaceutical companies are focusing on multiple drug delivery technologies for creating excellent advantages and better outcome for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market. Drugs used for COVID-19 treatment are both oral and injectable, however, a marginal increase is expected for pulmonary or respiratory-based drug delivery devices.

The regulatory changes related to medical devices is expected to restraint the growth of drug delivery devices market. The companies operating in the market are required to adapt according to the changes in the regulatory framework, which may limit business at the bottom line. Also, companies will have to bear the heavy cost of adapting to the changing regulatory framework. Also, the sudden changes in the regulatory framework related to medical devices can result in losses, fines, penalties at a global level. The new MDSAP will come into effect from 2020 and is adopted by regulators in the US, Canada, Japan, Brazil, and Australia. Following the changes, in Canada, all the medical device manufacturers including drug delivery products manufacturers, will have to comply with the requirements of MDSAP and are required to submit the MDSAP reports to the regulatory body in order to obtain or maintain the device licenses, resulting in high costs and time loss. Thus, the growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.

The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. The major players operating in the global microneedle drug delivery system include, 3M, Vetter Pharma International GmbH, nano Biosciences LLC, Nano Pass and more. The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once, the microneedles dissolve in the skin, the drug gets released. This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as to expand their footprint across different geographies. For example, in December 2019, Leo Pharma, a Danish pharmaceutical company, has collaborated with Portal Instruments to build Portal's advanced needle-free drug delivery system for use in conjunction with LEO Pharma's research and approved drug portfolio. This simplifies administration and removes the need for sharp containers at home, and also decreases the time required for self-injections.

In August 2020, Sulzer, a Swiss-based engineering and manufacturing firm acquired Haselmeier GmbH for $118m. The acquisition of Haselmeier will allow Sulzer to complement its healthcare portfolio, in addition to leveraging its APS expertise in precision injection moulding to expand its presence in the drug delivery devices market. Haselmeier GmbH, a Swiss-German drug delivery device developer and manufacturer.

Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc, Baxter International, BD, Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc, Bayer AG, and GlaxoSmithKline plc.

North America was the largest region in the drug delivery devices market in 2021. Asia Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the global drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug delivery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global drug delivery devices market is segmented -

1) By Route of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others

    Table Of Contents

    1. Executive Summary

    2. Drug Delivery Devices Market Characteristics

    3. Drug Delivery Devices Market Trends And Strategies

    4. Impact Of COVID-19 On Drug Delivery Devices

    5. Drug Delivery Devices Market Size And Growth

    5.1. Global Drug Delivery Devices Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Drug Delivery Devices Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Drug Delivery Devices Market Segmentation

    6.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral Drug Delivery

    Injectable Drug Delivery

    Topical Drug Delivery

    Ocular Drug Delivery

    Pulmonary Drug Delivery

    Nasal Drug Delivery

    Transmucosal Drug Delivery

    Implantable Drug Delivery

    6.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospitals

    Diagnostic Centers

    Ambulatory Surgery Centers/Clinics

    Home Care Settings

    Other Patient Care Settings

    6.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Cancer

    Infectious Diseases

    Respiratory Diseases

    Diabetes

    Cardiovascular Diseases

    Autoimmune Diseases

    Central Nervous System Disorders

    Other Applications

    7. Drug Delivery Devices Market Regional And Country Analysis

    7.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Drug Delivery Devices Market

    8.1. Asia-Pacific Drug Delivery Devices Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Drug Delivery Devices Market

    9.1. China Drug Delivery Devices Market Overview

    9.2. China Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Drug Delivery Devices Market

    10.1. India Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Drug Delivery Devices Market

    11.1. Japan Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Drug Delivery Devices Market

    12.1. Australia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Drug Delivery Devices Market

    13.1. Indonesia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Drug Delivery Devices Market

    14.1. South Korea Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Drug Delivery Devices Market

    15.1. Western Europe Drug Delivery Devices Market Overview

    15.2. Western Europe Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Drug Delivery Devices Market

    16.1. UK Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Drug Delivery Devices Market

    17.1. Germany Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Drug Delivery Devices Market

    18.3. France Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Drug Delivery Devices Market

    19.1. Eastern Europe Drug Delivery Devices Market Overview

    19.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Drug Delivery Devices Market

    20.1. Russia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Drug Delivery Devices Market

    21.1. North America Drug Delivery Devices Market Overview

    21.2. North America Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Drug Delivery Devices Market

    22.1. USA Drug Delivery Devices Market Overview

    22.2. USA Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Drug Delivery Devices Market

    23.1. South America Drug Delivery Devices Market Overview

    23.2. South America Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Drug Delivery Devices Market

    24.1. Brazil Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Drug Delivery Devices Market

    25.1. Middle East Drug Delivery Devices Market Overview

    25.2. Middle East Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Drug Delivery Devices Market

    26.1. Africa Drug Delivery Devices Market Overview

    26.2. Africa Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Drug Delivery Devices Market Competitive Landscape And Company Profiles

    27.1. Drug Delivery Devices Market Competitive Landscape

    27.2. Drug Delivery Devices Market Company Profiles

    27.2.1. BD/Becton, Dickinson

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Novartis AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Pfizer Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Johnson & Johnson Services, Inc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Gerresheimer AG

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Drug Delivery Devices Market

    29. Drug Delivery Devices Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: India, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Japan, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Australia, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Indonesia, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: South Korea, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Western Europe, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: UK, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Germany, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: France, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Eastern Europe, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Russia, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: North America, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: USA, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South America, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Brazil, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Middle East, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Africa, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: BD/Becton, Dickinson Financial Performance
  • Table 28: Novartis AG Financial Performance
  • Table 29: Pfizer Inc Financial Performance
  • Table 30: Johnson & Johnson Services, Inc Financial Performance
  • Table 31: Gerresheimer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: India, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Japan, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Australia, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Indonesia, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: South Korea, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Western Europe, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: UK, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Germany, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: France, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Eastern Europe, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Russia, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: North America, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: USA, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South America, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Brazil, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Middle East, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Africa, Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: BD/Becton, Dickinson Financial Performance
  • Figure 28: Novartis AG Financial Performance
  • Figure 29: Pfizer Inc Financial Performance
  • Figure 30: Johnson & Johnson Services, Inc Financial Performance
  • Figure 31: Gerresheimer AG Financial Performance
Global Anesthesia And Respiratory Devices Market Outlook, Opportunities And Strategies
Global Anesthesia Machines Market Outlook, Opportunities And Strategies
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Outlook, Opportunities And Strategies
Global Computed Tomography (CT) Scanners Devices And Equipment Market Overview And Prospects
Global Diabetes Care Devices Market Outlook, Opportunities And Strategies
Global Diagnostic Imaging Equipment Market Overview And Prospects
Global Drug Delivery Devices Market Size, Forecasts, And Opportunities
Global Injectable Drug Delivery Devices Market Size, Forecasts, And Opportunities
Analgesics Global Market Report 2022 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical), By Drug Type (Prescription Analgesics, OTC Analgesics), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Implantable Drug Delivery Devices Global Market Report 2022 – By Product (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps, Other Applications), By Technology (Diffusion, Osmotic, Magnetic, Other Technologies), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Implantable Infusion Pumps Global Market Report 2022 – By Type (Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps), By Application (Oncology, Pediatrics/Neonatology, Gastroenterology, Hematology, Diabetes), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Injectable Drug Delivery Devices Global Market Report 2022 – By Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors), By Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications), By End User (Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Nasal Splints Equipment Global Market Report 2022 – By Type (Malleable Nasal Splints, Airway Nasal Splints, Bivalve Nasal Splints), By End-User (Hospitals & Clinics, Homecare, Research Centers), By Application (Plastic Surgery, Rhinological operations, ENT-Surgery), By Route of Administration (Intranasal Segment, Extranasal Segment) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Ambulatory IV Infusion Pumps Market 2022 - By Therapy (Infusion Pumps, Anti-Infective Infusion Pump), By Patient Care Settings (Hospitals, Home Healthcare), By Application (Chemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Anti-Infective), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Oral Biologics & Biosimilar Drugs Global Market Report 2022 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn'S Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Oral Contraceptive Pills Global Market Report 2022 – By Type (Combination, Progestin Only), By Category (Generic, Branded), By Distribution Channel ( Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO)– Market Size, Trends, And Global Forecast 2022-2026
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)